Products

UltraGRO™-Advanced GMP grade

Product Type:FDhPL

Attribute:non-xenogeneic

Grade:GMP grade

Product Name:UltraGRO™-Advanced

Catalog Number:HPCFDCGL50, HPCFDCGL10, HPCFDCGL05

    • Description:

      UltraGRO™-Advanced cell culture supplement is a fibrinogen depleted, non-xenogeneic, animal serum-free supplement for replacing FBS (fetal bovine serum) to support cell expansion from research and clinical trials to commercial application. UltraGRO™-Advanced contains abundant growth factors and cytokines necessary for research or industrial cell growth and proliferation of multiple cell types (e.g. MSCs) in research-scale or industrial-scale production.

    • Specification:

      1. Appearance: Yellow to Buff liquid

      2. Total Protein: 4.0 - 8.0 g/dL

      3. pH: 6.5 - 8.5

      4. Osmolality: 275 - 355 mOsm/Kg

      5. Endotoxin: ≤ 10 EU/mL

      6. Mycoplasma: Not Detected

      7. Sterility: No Growth

      8. Performance Test: Test and record

      9. Fibrinogen: < 20 μg/mL

    • Storage and Shipping Information:

      UltraGRO™-Advanced is most stable when stored frozen until needed. The recommended storage temperature is -20°C. Thaw frozen UltraGRO™-Advanced product in 37°C water bath before use. Once UltraGRO™-Advanced is thawed, it is recommended to fully use for completed medium preparation (e.g. 5%) the same day, or to divide it into single-use aliquots and store unused aliquots at -20°C.

    • Packaging Information:

      500mL, 100mL, 50mL plastic bottles

    • Media Form:

      Frozen Liquid

    • Application:

      For human ex-vivo tissue and cell culture processing applications.

    • Instructions for Use:

      1. UltraGRO™-Advanced shows optimal growth of MSC at 5% (v/v) in typical cell culture media, i.e. α-MEM, which contains 2mM L-Glutamine as final concentrate.

      2. We recommend seeding MSCs at approximately 3x103~6x103 per cm2.

      3. UltraGRO™-Advanced has been fibrinogen-depleted and does not require the addition of heparin in the cell culture media.

    • Cell Lines:

      bone marrow mesenchymal stem cells, adipose tissue derived mesenchymal stem cells, umbilical cord derived mesenchymal stem cells, other mesenchymal stem cells

    • Important Information:

      1. Insoluble particles may form in thawed UltraGRO™-Advanced. Published research has shown that particles will not alter the performance of the product.

      2. Insoluble particles may form in thawed UltraGRO™-Advanced, it is recommended to centrifuge at 3,400 xg for 3~5 minutes.

      3. Filtering the completed medium (e.g. 5%), after UltraGRO™-Advanced is diluted in the basal medium, will not affect UltraGRO™-Advanced supplemented cell culture performance. However, 0.22 μm filtering is NOT recommended for the 100% UltraGRO™-Advanced concentrate, as this may reduce 5% UltraGRO™ -Advanced cell culture performance.

      4. Repeated freeze-thaw cycles should be avoided as they will cause an increase in insoluble precipitates and resulting potential decrease in UltraGRO™-Advanced performance.

    • Safety Packaging information:

      1. Follow the handling instructions outlined in the Material Safety Date Sheets (MSDSs). Wear appropriate protective eyewear, clothing, and gloves.

      2. UltraGRO™-Advanced is a cell culture supplement derived from human platelets collected from healthy donors at FDA licensed blood centers. Each donor has been tested using FDA licensed tests and found nonreactive for HBsAg, Hepatitis B core antibody (anti-HBc), HIV antibody (anti-HIV-1/2), Hepatitis C antibody (anti-HCV), HTLV-1/2 antibody (anti-HTLV-1/2), Trypanosoma cruzi antibody (anti-T. cruzi), HIV-1, HCV, HBV, WNV nucleic acid testing and Syphilis microhemagglutination test. Each donation is tested for ZIKV under either and FDA licensed test or an investigational ID-NAT test and found non-reactive.

      3. This product is manufactured, tested and released in compliance with the relevant GMP guidelines. This product is for in vitro use only.

    • US FDA Drug Master File:

      UltraGRO™-Advanced has filed a Type II Drug Master File (DMF). Please contact sales@atcbiomed.com for further information.